Sanofi Considering Acquisition of Mirati Therapeutics, Bloomberg Reports
06 Outubro 2023 - 3:56AM
Dow Jones News
--Sanofi is considering a potential acquisition of Mirati
Therapeutics Inc., a San Diego-based biotechnology company focused
on cancer drugs, Bloomberg reports, citing unnamed sources.
--Mirati could draw interest from other suitors and there is no
certainty that the French pharmaceutical giant's deliberations will
result in a deal, according to Bloomberg.
--Sanofi and Mirati didn't immediately respond to requests for
comment from Dow Jones Newswires.
Full story: https://shorturl.at/lIR39
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 06, 2023 02:41 ET (06:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Mirati Therapeutics (NASDAQ:MRTX)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Mirati Therapeutics (NASDAQ:MRTX)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024